FRI0430 THE NOVEL, INTRA-ARTICULAR CLK/DYRK1A INHIBITOR LORECIVIVINT (LOR; SM04690), WHICH MODULATES THE WNT PATHWAY, IMPROVED RESPONDER OUTCOMES IN SUBJECTS WITH KNEE OSTEOARTHRITIS: A POST HOC ANALYSIS FROM A PHASE 2B TRIAL
医学
沃马克
骨关节炎
安慰剂
析因分析
物理疗法
膝关节痛
内科学
病理
替代医学
作者
Yusuf Yazıcı,Sarah J. Kennedy,Christopher J. Swearingen,J. Tambiah